FdaApplication
ANDA 213154
Identifiers
- fda_app_no: ANDA213154
Properties
| Property | Value |
|---|---|
| applicant_name | NATCO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2025-02-05 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BOSENTAN | BOSENTAN | 32MG | TABLET, FOR SUSPENSION;ORAL |
1 product